Invitation to Bid - Diclofenac 25 mg/ml IP, 3 ml Inj in WEST DELHI, DELHI

The eligibility requirements include being a registered entity with proven experience in supplying pharmaceutical products. Bidders must demonstrate a minimum average annual turnover of INR 6 Lakh for the past financial years, alongside three years of experience in supplying similar products. Additionally, MSEs and startups may qualify for exemptions related to experience.

For this tender, the required certificates include the Experience Certificate, Past Performance documentation, Bidder Turnover details, OEM Authorization Certificate, and proof of Compliance with the BoQ. Documentation should be comprehensive and submitted in the defined formats to ensure eligibility for evaluation.

The financial requirements stipulate a mandatory Earnest Money Deposit (EMD) of INR 50,000. Bidders must outline their payment terms clearly, adhering to governmental regulations for procurement and ensuring the submission of competitive pricing.

Bids must be submitted electronically through the designated online portal, ensuring compliance with all document submission requirements. Key timelines and deadlines will be detailed in the tender documentation, guiding bidders on submission procedures and cut-off dates for considerations during the evaluation process.

Yes, this tender incorporates provisions for MSEs and startups, allowing these businesses to benefit from exemptions related to years of experience required. This initiative aims to promote participation from smaller enterprises and encourage local procurement in alignment with the 'Make in India' policy, fostering a diverse supplier base.